23andMe CEO plans to take company private
Bio Pharma Dive
APRIL 18, 2024
Company head Anne Wojcicki is considering buying all outstanding shares of the DNA testing firm, which has seen its stock slump in recent years.
Bio Pharma Dive
APRIL 18, 2024
Company head Anne Wojcicki is considering buying all outstanding shares of the DNA testing firm, which has seen its stock slump in recent years.
Bio Pharma Dive
JANUARY 18, 2024
Called Advanced Medicine Partners, the new company will offer specialized cell and gene therapy manufacturing services to biotech and pharma clients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
OCTOBER 18, 2023
CEO Emil Kakkis says the company's findings are too exciting to ignore, but the “high-risk, high-return” venture needs to be pursued outside the organization.
Pharmaceutical Technology
MARCH 25, 2024
Download our extensive, free list of the leading pharmaceutical packaging companies and labelling machine manufacturers today.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials.
Pharmaceutical Technology
MAY 8, 2023
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.
Pharmaceutical Technology
AUGUST 1, 2023
BioNTech has acquired all the remaining shares of technology company InstaDeep in a deal valued at €500m ($549m) in cash.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Advertisement
The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinical trials.
Speaker: Steve Goldstein, Sales Leader
Former VP, Sales for $15 Billion Medical Supply Company. Simple strategies to become more memorable to your customer, thus maximizing your sales success. Who is Steve Goldstein and what are his credentials? Coached over 2000 sales reps worldwide. Toastmasters Champion. Dale Carnegie Sales Coach/Human Relations Award Winner.
Let's personalize your content